Cardiovascular diseases in patients with renal disease: Epidemiology, pathophysiology and therapy [Kardiovaskuläre Erkrankungen bei Patienten mit Nierenerkrankungen: Epidemiologie, Pathophysiologie und Therapie]

被引:0
|
作者
Holubarsch C.J.F. [1 ]
机构
[1] Lazariterhof und Klinik Baden, Median-Kliniken Bad Krozingen, 79189 Bad Krozingen
关键词
Chronic kidney disease; coronary artery disease; end-stage renal disease; homocysteine; leptin; renin-angiotensin-system;
D O I
10.1007/s11789-006-0030-0
中图分类号
学科分类号
摘要
Myocardial infarction, sudden cardiac death, chronic heart failure, and cerebrovascular insult are the most frequent diseases in western countries. The classical risk factors underlying these cardiovascular diseases are very well known: Diabetes mellitus, arterial hypertension, hyperlipoproteinemia, nicotin abuse and adipositas/ obesity as well as physical inactivity. During the last decade scientists have especially focussed on the association between diabetes (especially metabolic syndrome) and coronary artery disease. However, all of these coronary risk factors also have an influence on renal function: For example, endstage renal disease is the result from diabetes mellitus in 33% and from arterial hypertension in 22% of patients. On the other hand, the degree of renal function disturbance correlates well with the occurrence of cardiovascular events. Therefore, from a statistical point of view, renal insufficiency is not only an indicator or barometer for the cardiovascular risk factors, but rather a risk factor sui generis, i. e., it defines prognosis of patients. In this context, it is of special interest that patients with renal failure are not adaequately treated compared to other patients - regarding invasive as well as noninvasive medical strategies. © 2007 Springer Medizin Verlag.
引用
收藏
页码:S9 / S14
页数:5
相关论文
共 50 条
  • [11] Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic; [Diabetes und kardiovaskuläre Erkrankung: Pathophysiologie einer lebensbedrohlichen Epidemie]
    King R.J.
    Grant P.J.
    Herz, 2016, 41 (3) : 184 - 192
  • [12] Wichtigste Impfungen bei Patienten mit rheumatologischen Erkrankungen und warumMost important vaccinations in patients with rheumatological diseases and why
    C. Kneitz
    U. Müller-Ladner
    Zeitschrift für Rheumatologie, 2020, 79 (9) : 855 - 864
  • [13] Prevention and treatment of venous thromboembolism in cancer patients; [Prophylaxe und Therapie venöser Thromboembolien bei Patienten mit malignen Erkrankungen]
    Spehlmann M.-E.
    Frey N.
    Müller O.J.
    Herz, 2020, 45 (7) : 652 - 658
  • [14] Cardiovascular disease in patients with chronic kidney diseaseHerz-Kreislauf-Erkrankungen bei Patienten mit chronischer Nierenerkrankung
    Nikolaus Marx
    Jürgen Floege
    Herz, 2021, 46 (3) : 205 - 205
  • [15] Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw; [Osteoporosetherapie bei Patienten mit entzündlich-rheumatischen Erkrankungen und Kieferosteonekrosen]
    Schwaneck E.C.
    Streit A.
    Krone M.
    Hartmann S.
    Müller-Richter U.
    Kübler A.C.
    Gadeholt O.
    Schmalzing M.
    Tony H.-P.
    Brands R.C.
    Zeitschrift für Rheumatologie, 2020, 79 (2) : 203 - 209
  • [16] Neuro-urological dysfunction of the lower urinary tract in CNS diseases. Pathophysiology, epidemiology, and treatment options [Neurourologische funktionsstörungen des unteren harntraktes bei erkrankungen des ZNS: Pathophysiologie, epidemiologie und therapieoptionen]
    Mehnert U.
    Nehiba M.
    Der Urologe, 2012, 51 (2): : 189 - 197
  • [17] Comorbidity in patients with musculoskeletal and cardiovascular diseases: Prevalence rates, diagnosis and consequences for rehabilitation [Komorbidität bei patienten mit muskuloskelettalen und kardiovaskulären erkrankungen: Prävalenzen, diagnosen and konsequenzen für die rehabilitation]
    Härter M.
    Hahn D.
    Baumeister H.
    Reuter K.
    Wunsch A.
    Bengel J.
    Journal of Public Health, 2004, 12 (3) : 162 - 167
  • [18] Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit DiabetesComments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes
    Nikolaus Marx
    Dirk Müller-Wieland
    Christine Espinola-Klein
    Martin Halle
    Annette Birkenhagen
    Patrick Diemert
    Felix Mahfoud
    Harm Wienbergen
    Katharina Schütt
    Die Kardiologie, 2024, 18 (3) : 256 - 265
  • [19] Association between lipoprotein(a) and cardiovascular disease in patients undergoing coronary angiographyZusammenhang zwischen Lipoprotein(a) und Herz-Kreislauf-Erkrankungen bei Patienten mit Koronarangiographie
    Azhi ShaMa
    Chunmei Xu
    Yingying Huang
    Chunlan Ma
    Jingyue Hu
    Zhuxin Li
    Chunyu Zeng
    Herz, 2024, 49 (5) : 378 - 384
  • [20] Recommendations for diagnosis and treatment of patients with coronary heart disease and renal failure: Part II: Therapy, percutaneous coronary intervention, bypass surgery and specific aspects of renal and cardiovascular disease [Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz: Teil II: Therapie, perkutane koronare Intervention, Bypass-Chirurgie und spezielle Aspekte bei Niereninsuffizienz und kardiovaskulären Erkrankungen]
    Reinecke H.
    Brandenburg V.
    Dominiak P.
    Flöge J.
    Galle J.
    Geiger H.
    Grabensee B.
    de Haan F.
    Heun K.
    Ivens K.
    Krian A.
    Kroll J.
    Kutkuhn B.
    Mann J.
    Philipp T.
    Risler T.
    Strauer B.E.
    Thiel W.
    Breithardt G.
    Clinical Research in Cardiology Supplements, 2006, 1 (2) : 103 - 117